Search PubMed⌕ Search

Biomedical subjects

C Frances

Publications and source records attributed to C Frances.

117 records · Page 7Linked to original sources
PubMedDate not supplied

Elastic fibers in normal human skin. Variations with age: a morphometric analysis.

A quantitative study of dermal elastic fibers was carried out by computerized digital image analysis. Sections of skin biopsies taken from the upper inner arm of 33 healthy women and 38 healthy men were stained by a selective procedure for elastic fibers. The Leitz texture analysis system (Leitz-Tas) and mathematical morphology were used for the evaluation of the data. Distinct programs were used for the vertical superficial elastic fibers and for the mature elastic fibers of the reticular dermis. For elastic fibers of the superficial dermis there was no significant variation with age or sex for total area occupied by the fibers or for the total number of fibers per unit skin area or total fiber length. The distribution of the relative fiber number as a function of their length showed that about 80% of the fibers had a length of 0-20 microm, with no detectable age- or sex-dependent variation. The distribution of fiber number frequency as a function of fiber diameter did not show any significant variation with sex or age, either. The relative area of mature elastic fibers increased significantly with age after the sixth decade of life. The total number (Nt) of these fibers did not show however any significant variation with age or sex: Nt per mm(2) of skin surface was 3220+/-660 (S.D.). We found for all age groups a significant increase of total fiber length by comparing persons between 20 and 30 years with those above 60 years. There was, however, no significant variations according to age or sex for the frequency distribution of mature elastic fiber length and diameter. As a significant decrease with age of the dermal thickness was also found in males and females, the loss of elastic fibers with age is mainly due to a loss of skin thickness (skin volume) with age. This loss is about 30% at 50 years and nearly 50% at 80 years. Loss of skin elasticity with age can be due to loss of cells (fibroblasts), to a decrease of their biosynthetic activity and to qualitative modifications of extracellular matrix macromolecules.

Journal Article↗
PubMedDate not supplied

Morphometric analysis of dermal collagen fibers in normal human skin as a function of age.

A quantitative study of dermal collagen as a function of age was carried out by computerized digital image analysis. Fast Green-Syrius Red stained sections were obtained of skin biopsies taken from the upper inner arm of 33 healthy women and 38 healthy men. The Leitz texture Analysis System (Leitz-TAS) and mathematical morphology (Serra, 1982) were used for the evaluation of the data. Collagen was studied in the superficial dermis and also in the reticular dermis using the same program. There were significant correlations, firstly between the percentage of collagen measured by the morphometric method and the concentration of collagen analysed biochemically (microg/mm(2) of tissue section) (r = 0.79, p < 0.001) and secondly between the decreased concentration of collagen and age (r = 0.58, p < 0.05). The morphometrical measurements have shown that the relative percentage of collagen bundles (surface of collagen fibers as a function of the dermal area analyzed) was 93.35% in the superficial dermis and 89.2% in the reticular dermis. Although this value is higher than the chemically determined ratio of collagen to other proteins (over 70%), this may be due to the relatively uniform distribution pattern of (type I and III) collagen through the dermis covering most other components of the skin. As the collagen fiber density per unit dermal surface did not change with age, the decrease in collagen content of the skin may be ascribed to the loss of about 6% of dermal mass per decade (Branchet, 1990), although large individual variations exist. The histogram of the diameter distribution of collagen fiber bundles of the reticular dermis showed thinner diameters in persons between 20 and 40 years of age than in older persons. The histogram of the distribution of interfiber spaces did not show any variation with age in the superficial dermis, while in the reticular dermis there was a predominance of smaller interspaces in persons older than 50 years.

Journal Article↗
PubMedDate not supplied

[Not Available].

Explore the source record for details and available documents.

History of Pharmacy↗
PubMedDate not supplied

[Utilization of methylphenidate(Ritalin) in France].

Methylphenidate (Ritalin) is the only psychostimulant approved in France and indicated in attention deficit hyperactivity disorder in children over 6 years. It is under restricted prescription and distribution conditions. As such, it requires a hospital initiated prescription from either a neurology, psychiatry or pediatric specialist and it is covered by the "narcotics" schedule. The French Pharmacovigilance database spontaneous adverse drug reactions reporting, since it was approved in 1995, were analyzed. 21 adverse drug reactions were reported. In 16 cases, methylphenidate was suspected. They were generally non-serious, mild side effects and in most cases promptly resolved. These results do not suggest methylphenidate misuse in France or an overuse in between 1300 and 4000 treated children, to date. Until more information is available concerning the long-term effects of methylphenidate, and in order to limit misuse, inappropriate or overuse, the current prescription and dispensing regulation should be maintained in France, and could well be developed in other countries.

Attention Deficit Disorder with Hyperactivity↗
PubMedDate not supplied

Efficiency of amifostine as a protection against doxorubicin toxicity in rats during a 12-day treatment.

BACKGROUND: Our purpose was to determine the effects of amifostine, a cytoprotective agent, on doxorubicin tolerance and cardiotoxicity in rats. MATERIALS AND METHODS: Male Wistar rats were treated every other day with an intraperitoneal injection of amifostine or saline 30 minutes before intraperitoneal injection of doxorubicin or saline. Weight change was recorded, and contractile function was evaluated after 11 injections by means of the isolated heart. RESULTS: Weight evolution and cardiac function were significantly improved by 7 and 20 mg/kg amifostine (p < 0.001) but not by 50 mg/kg. The final weight were: controls 349 +/- 16 g; doxorubicin alone 258 +/- 54 g; with amifostine: 7 mg/kg 314 + 28 g; 20 mg/kg 312 +/- 32 g; 50 mg/kg 250 +/- 34 g. Left ventricular developed pressure were: controls 137 +/- 15 mmHg; doxorubicin alone 119 +/- 20 mmHg; with amifostine: 7 mg/kg 140 +/- 20 mmHg; 20 mg/kg 137 +/- 25 mmHg; 50 mg/kg 124 +/- 20 mmHg. CONCLUSION: Seven and 20 mg/kg amifostine protected rats from the toxicity of doxorubicin at the cumulative dose of 18 mg/kg during a 12-day treatment, with regard to weight loss and heart contraction.

Amifostine↗